Arkolith/Insider Trading/MAZE/Form 4

Coloma Jason V

Chief Executive Officer, DirectorMaze Therapeutics, Inc. (MAZE) · full profile →Form 4 · filed Jul 2, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.0M
Net Open-Market Flow
-$1.0M
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 1, 2026Sell(S)3K$29.98$78K23K
Jul 1, 2026Sell(S)30K$29.95$908K289K
Jul 1, 2026Sell(S)2K$30.44$49K287K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001676170-26-000014) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML